PET DIABETES CARE DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Pet Diabetes Care Devices Market Size and Trends

The global pet diabetes care devices market is estimated to be valued at USD 2.60 Bn in 2025 and is expected to reach USD 4.26 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. 

To learn more about this report, Request sample copy

Key Takeaways

• Based on Animal Type, the Dog segment leads the market holding an estimated share of 59.6% in the market in 2025, owing to popularity as companion pets globally.
• Based on Solution, the Treatment segment is projected to hold the market share of 55.5% in 2025 attributed to need for effective glycemic control in diabetic pets.
• Based on End User, the Veterinary Clinics segment is expected to lead the global pet diabetes care devices market with 40.5% share in 2025, owing to their prominent role in pet diabetes diagnosis and management.
• Based on region, North America is expected to lead the market, holding a share of 40.8% in 2025, owing to its highest pet ownership rate in the world. While, Asia Pacific is anticipated to be the fastest growing region during the forecast period.

Market Overview

The global pet diabetes care device market is growing due to the rising prevalence of diabetes in pets owing to obesity and lack of physical activity as well as increasing pet ownership globally is expected to drive the demand for pet diabetes care devices over the forecast period. Diabetes is a common metabolic disorder affecting both cats and dogs. In pets, diabetes is caused due to the body’s inability to properly regulate blood sugar level, cause by the problem with insulin production or action.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Request sample copy

Pet Diabetes Care Devices Market Insights, By Animal Type - Dog ownership drives the demand for canine diabetes care

In terms of animal type, dogs’ segment is expected to contribute the highest share of the market, accounting for 59.6% in 2025 owing to their popularity as companion pets globally. Many families consider dogs an essential part of the household and are willing to invest heavily in their health and wellbeing. As dogs have longer lifespans now due to advancements in veterinary care, they are also susceptible to age-related illnesses such as diabetes just as humans are. This "pet parent" attitude leads to higher spending on diabetes management products for dogs compared to other pet types. Additionally, certain dog breeds have a genetic predisposition to diabetes which contributes to the growing caseload. Increased public awareness about pet health through social media also drives more proactive diabetes screening and treatment seeking for symptomatic dogs. Overall, the deep emotional bonds and investment through people have the dogs segment a primary factor supporting the pet diabetes care devices market growth.

For instance, in march 2025, a 3-year-old male pug has been wearing the ‘continues glucose monitor’ (CGM) for uncontrolled blood sugar levels, placed by the Mumbai Veterinary College. This tech device will help in keeping track of his glucose levels. The CGM is a circular patch pinned on the abdominal region, or nape (the region above the neck) of the animal. It is linked io the smartphone through a sensor which lines for two weeks. The apps display the glucose level. The normal blood glucose level ranges between 80 to 120 mg/dl but in this the pug had a blood glucose level above 400 mg/dl.

Pet Diabetes Care Devices Market Insights, By Solutions - Treatment modalities drive the demand for solutions

In terms of solutions, treatment is expected to contribute the highest share of the market with 55.5% share in 2025 driven by the need for effective glycemic control in diabetic pets. For pets diagnosed with diabetes, lifelong treatment is required through a combination of insulin therapy, glucose monitoring, and other supporting therapies. Insulin injections administered either by the owner or a veterinarian remain the standard of care for controlling blood sugar levels in both cats and dogs. This steady demand for insulin therapy consistently drives the insulin delivery devices and syringes segment of the market. The important role played by glucose monitoring devices is also rising as more pet owners have become accustomed to routinely checking their pet's blood glucose levels using test strips. Given that uncontrolled diabetes can lead to severe health issues in pets, these monitoring tools aid early intervention. Adjunct treatments like dietary adjustments and supplements also see uptake based on veterinary recommendations to manage diabetes complications long-term. With no permanent cure available, ongoing treatment forms the backbone of diabetes solutions sought for affected pets.

In February 2025, there is a significant development for feline diabetes management. At the London Vet Show, veterinary experts highlight the benefits of velagliflozin (marketed as Senvelgo), a once-daily oral medication that offers an alternative to traditional insulin injections for cates. Velagliflozin promotes glucose excretion through the kidneys, aiding in blood sugar control.

Pet Diabetes Care Devices Market Insights, By End User - Veterinary clinics anchor customer base

In terms of end user, veterinary clinics is expected to contribute the highest share of the market with 40.5% share in 2025 owing to their prominent role in pet diabetes diagnosis and management. As the frontline healthcare providers for pets, veterinary clinics are typically the first point of contact when an owner notices symptoms of diabetes in their pet. Clinics perform the required diagnostic tests to formally establish hyperglycemia and classify the type and severity of diabetes. Post-diagnosis, clinics assume responsibility for educating owners about treatment protocols, demonstrating insulin administration techniques, dispensing insulin and device prescriptions, monitoring response to medications, and adjusting therapies as needed. They also stock a variety of diabetes products and consumables on their premises for fill and refill orders. Clinics thus act as trusted consultants to owners navigating their pet's diabetes journey. While clinics refer some routine care tasks to owners for home management, they remain the primary care providers overseeing the long-term medical supervision pets need. This established clinical relationship drives the majority of demand for diabetes care devices within the channel of veterinary clinics.

For instance, in September 2024, Veterinary clinics across the United States received access to complimentary diabetes management tools through the Diabetes PetCare Alliance program, a collaborative initiative by Merck Animal Health, Pro Plan Veterinary Diets, and Zoetis. This program aims to support pet owners in managing diabetes in their animals by providing educational resources and starter kits. This kit includes, an AlphaTRAK 3 Blood Glucose Monitoring System from Zoetis, a 6 lb bag of Purina Pro Plan Veterinary Diets DM Dietetic Management Feline Formula or EN Gastroenteric Fiber Balance Canine Formula, and a 10 mL vial of Vetsulin (porcine insulin zinc suspension) from Merck Animal Health.

Regional Insights

To learn more about this report, Request sample copy

North America Pet Diabetes Care Devices Market Analysis and Trends

North America has established itself as the dominant region in the global pet diabetes care devices market. It is expected hold a market share of 40.8% in 2025. This can be attributed to several factors. The U.S. has the highest pet ownership rate in the world, with over 66% of American households owning a pet in 2023, this reflects to approximately 85.9 million families. With rising pet obesity rates, diabetes in companion animals is also on the rise. This has boosted the demand for blood glucose monitoring equipment and insulin delivery devices among pet owners in the region. Additionally, North America is home to some of the largest pet pharmaceutical companies that are continuously investing in R&D for novel diabetes care solutions. Being an early adopter of new medical technologies, veterinary clinics and hospitals in the U.S. and Canada are well-equipped with the latest pet diabetes management devices.

Asia Pacific Pet Diabetes Care Devices Market Analysis and Trends

Asia Pacific has emerged as the fastest growing regional market for pet diabetes care devices. Countries like China, India, and Japan have witnessed exponential growth in pet care expenditures over the past decade due to rapid urbanization, higher disposable incomes, and shifting cultural preferences. This has led to an increased awareness about pet health issues like diabetes. However, diabetes management previously involved sourcing insulin and vet prescriptions from overseas which drove up costs. But increased local manufacturing of companion animal healthcare products has made pet diabetes care therapy accessible and affordable in Asia Pacific. This has improved diagnosis and treatment rates, significantly boosting demand. Further foreign investments and collaborations between multinational companies and regional animal health startups are also spurring innovations suited to the preferences of Asian pet owners.

For Instance, in April 2025, the Food and Agriculture Organization of the United Nations (FAO) formed a strategic alliance with the Australian Government, to initiate a 3-year regional project aimed at boosting animal health systems across Southeast Asia and the Pacific. The aim is to enhance disease prevention, detection, and response by developing resilient, inclusive, and sustainable veterinary infrastructures.

Pet Diabetes Care Devices Market Outlook Country-wise

The United States Pet Diabetes Care Devices Market Trends

The U.S. pet diabetes care device market growth is driven by high pet ownership rate, increasing pet obesity and diabetes cases and widespread availability of advanced pet healthcare technology. In the US, an estimated 1 in 300 adult canines and 1 in 230 cats are living with diabetes. Although the disease is not curable, the earlier a diagnosis can be made and the more educated owners are the better the odds of pets living long, healthy lives.

Germany Pet Diabetes Care Devices Market Trends

Germany’s pet diabetes care devices market growth is driven by strong veterinary infrastructure, high disposable income among pet owners and growing diabetic pet population. EU also has a strict animal welfare and medical device regulations which encourage the high-quality product standards. In 2025, Germany has approximately 11,309 veterinary service businesses and around 41,000 certified veterinarians providing care throughout the country.

Market Concentration and Competitive Landscape

To learn more about this report, Request sample copy

Recent Developments

• In May 2025, GoodRx launched GoodRx for pets, a platform designed to help pet owners manage their pets' health conditions, including diabetes, more effectively.
• In April 2025, Australian researchers developed a wearable device- 'Fitbit' for animals the devices transform health monitoring practices for creatures ranging from racehorses to military dogs. This innovative project is funded by the NSW Smart Sensing Network (NSSN) Grand Challenge, is a collaborative effort involving Macquarie University, the University of Sydney, and Perth-based industry partner VetChip.
• In July 2024, Dechra Limited, a specialist in veterinary pharmaceuticals and related products business, has purchased the long-acting veterinary insulin programs from Akston Biosciences Corporations. This program offers Dechra with the ownership of the intellectual property and rights for the development, manufacturing, and worldwide commercialization of the canine and feline candidate therapies.
• In November 2023, Boehringer Ingelheim received European approval for SENVELGO, the first oral liquid medication for diabetic cats. This groundbreaking treatment simplifies feline diabetes management by allowing a once-daily dosage, either mixed with food or administered directly.

Market Report Scope

Pet Diabetes Care Devices Market Report Coverage

Pet Diabetes Care Devices Market Driver

Increasing awareness about pet health and wellness

In recent years, people have become much more aware about the health and well-being of their pets. Just like humans, pets can suffer from various diseases if proper care is not taken. Owners have started to pay closer attention to their pet's diet, exercise routines, and overall lifestyle. They want to ensure their furry companions live a long and healthy life. This increasing focus on pet health has led more owners to regularly take their dogs and cats for checkups and medical examinations. Veterinarians play a big role in educating pet parents about common ailments and how to monitor for signs of illnesses. As people continue to treat their pets as valued family members, preventive healthcare is gaining prominence. Diabetes is one such condition that veterinarians have been helping owners identify early. They explain how just like in humans, pets too can become diabetic if their pancreas stops producing enough insulin or if cells stop responding to the insulin produced. Left unmanaged, diabetes can lead to severe problems affecting organs and overall quality of life in pets. Therefore, veterinary professionals advise routine tests for diabetic’s symptoms so the disease can be controlled through diet, exercise and medication. Some may even need insulin injections or advanced diabetes care devices. With growing awareness about diabetes in general, many owners have become familiar with its symptoms and risks for pets. They no longer consider it just a human disease but also diligently check their dog or cat's urine and watch for excessive thirst or hunger.

In May 2025, San Antonio Animal Care Services (SAACS) organized a new Humane Pet Care Awareness Campaign aimed at promoting responsible pet ownership, with a particular focus on the importance of spaying and neutering pets.

Rising incidence of diabetes

Along with awareness, the actual incidence of diabetes is rising rapidly in pets over the past decade. For example, in 2020, it was estimated that diabetes would affect approximately 1 in every 300 dogs and 1 in every 230 cats over the course of their lives. Certain breeds of dogs such as Poodles, Dachshunds and Terriers have a higher genetic risk for the disease. Even cats are quite prone to diabetes, especially older and obese felines. The core reasons attributed to increased diabetes cases are unhealthy pet diets, lack of exercise, and growing rates of obesity. Much like humans, pets too are victims of consuming low-quality commercial foods filled with carbohydrates, salts, and fats. Coupled with a sedentary lifestyle lacking physical activity, this has contributed substantially to weight gain issues across dog and cat populations. Excess weight is a major diabetes risk factor and the sizes of pet animals have ballooned over the years due to unhealthy dietary habits. While genetic predisposition cannot be altered, modifiable lifestyle factors associated with diabetes are well within control. With more owners now conscious about healthy pet nourishment and lifestyle maintenance, preventive approaches can help stem the diabetes tide. Still, the reality remains that more pets will require careful continuous glucose monitoring and advanced treatment solutions in the foreseen future.

Pet Diabetes Care Devices Market Opportunities

Development of affordable point-of-care diabetic care solutions for pets

One of the major opportunities present in the global pet diabetes care devices market is the development of more affordable point-of-care solutions. Currently, many pet owners find it difficult to regularly monitor their pets' blood glucose levels or administer insulin treatment due to the significant recurring costs involved. This gap in the market has opened up scope for companies to develop low-cost yet efficacious point-of-care devices especially tailored for convenient diabetes care of pets at home. Such affordable solutions could include portable blood glucose meters with discounted test strips, simplified insulin pens or patches, and miniaturized insulin pumps for easier measurement and administration of medication by pet owners. Catering to price-sensitive customers through value-based product offerings will help gain greater penetration in emerging markets and appeal to a wider customer segment globally. It can be a lucrative strategy for manufacturers to tap into this largely untapped opportunity of providing budget-friendly point-of-care options.

Analyst Opinion (Expert Opinion)

• The pet diabetes care devices market is grossly under-leveraged—stifled not by a lack of innovation, but by risk-averse veterinary channels and regulatory inertia. The market remains stuck in reactive care, primarily dependent on decades-old insulin delivery and glucose monitoring paradigms, while ignoring the behavioral realities and economic willingness of modern pet owners.
• Despite the evident success of humanized insulin pen devices in companion animals, adoption rates remain low outside North America. According to 2023 AVMA data, only 12% of diabetic pets in the U.S. are treated using insulin pens. Yet, anecdotal evidence from Banfield Pet Hospital's internal survey of 120 clinics indicates a 40% increase in owner compliance when switching from syringes to pens—driven purely by ease of use and reduced perception of invasiveness.
• CGMs like FreeStyle Libre (adapted for pets in university trials) are revolutionizing glycemic tracking. A 2022 study by the Royal Veterinary College showed that CGMs provided more accurate insulin titration in 86% of feline subjects compared to periodic blood sampling. Yet, penetration in general practice clinics remains under 3%. The gap? Economics and education. While pet owners shell out $60+ monthly on dental chews and tailored diets, the average clinic fails to present CGMs as essential rather than optional. This is not a pricing problem—it’s a positioning failure.
• The convergence of pet tech with diabetes care is being delayed not by technology, but by siloed development. Smart feeders are already commonplace—PetSafe reported a 20% YoY growth in sales of programmable feeders—but none integrate insulin administration. There is zero excuse for this disconnect. If diabetic children can be supported with closed-loop systems, so can pets. Yet not a single commercial IoT-enabled insulin pump is on the market for animals. This is not a future opportunity—it’s a present-day oversight.
• Veterinary resistance to adopting new device protocols is masking real consumer demand. In a 2023 Chewy survey, 72% of pet parents managing diabetic animals reported being willing to spend more for devices that offer “reduced manual dosing or real-time alerts.” This is consistent with the broader trend of "humanization" of pet care—pet parents expect the same tech stack for pets as for themselves. But the veterinary industry is lagging, defaulting to conservative treatment plans out of caution and legacy training models.

Market Segmentation

• Animal Type Insights
  • Dogs
  • Cats
•  Solutions Insights
  • Treatment
    • Insulin Therapy
    • Insulin Delivery Devices
    • Other Treatments
  • Glucose Monitoring Devices
•  End User Insights
  • Veterinary Clinics
  • Home Care Settings
  • Veterinary Hospitals
• Regional Insights
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Abbot Laboratories, Inc
  • Virbac
  • Medtronic plc
  • Johnson & Johnson Services, Inc
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc
  • Novo Nordisk A/S
  • Zoetis Inc
  • Terumo Corporation
  • Boehringer Ingelheim International GmbH
  • IDEXX Laboratories
  • Johnson & Johnson Services, Inc
  • Terumo Corporation
  • Eli Lilly and Company
  • Vetoquinol S.A.
  • i-SENS, Inc.

Sources

Primary Research Interviews from the following stakeholders

Stakeholders

• Interviews with veterinary endocrinologists, pet diabetes care device manufacturers, animal health technologists, veterinary clinic managers, pharmacists, pet insurance advisors, and procurement heads at veterinary hospital chains and pet retail brands.

Specific stakeholders

• Veterinary endocrinology specialists at animal hospitals and teaching veterinary institutions (e.g., Royal Veterinary College, Cornell University College of Veterinary Medicine)
• Product development leads at pet diabetes device manufacturers (e.g., glucose monitors, insulin pens, smart feeding systems)
• Operations managers at veterinary clinic chains (e.g., Banfield Pet Hospital, VCA Animal Hospitals)
• Procurement and retail managers at pet product retailers (e.g., Petco, Pets at Home, Chewy)
• R&D professionals in animal health technology firms
• Animal care specialists and diabetes care trainers at pet welfare NGOs and zoos
• Digital health integration leads working on connected pet health ecosystems
• Pharmacists specializing in animal insulin and related consumables

Databases

• U.S. Food and Drug Administration (FDA) – Animal and Veterinary section
• World Organisation for Animal Health (WOAH) data repository
• U.S. Department of Agriculture (USDA) – Animal and Plant Health Inspection Service (APHIS)
• European Medicines Agency (EMA) – Veterinary Medicinal Products database
• Pet Industry Joint Advisory Council (PIJAC) Data Archives
• Animal Health Institute (AHI) – Statistics and Trends
• Global Pet Expo Data Reports
• Japan Veterinary Medical Association – Annual Market Statistics
• Australian Bureau of Agricultural and Resource Economics and Sciences (ABARES)

Magazines

• Today’s Veterinary Business
• Veterinary Practice News
• Pet Product News International
• Animal Pharm
• Vet Times
• Global Pets
• The Veterinary Record
• Companion Animal Journal
• Pet Age

Journals

• Journal of Veterinary Internal Medicine
• Veterinary Record Open
• Journal of Animal Science
• Veterinary Therapeutics
• Journal of Veterinary Pharmacology and Therapeutics
• Domestic Animal Endocrinology
• Journal of Feline Medicine and Surgery
• BMC Veterinary Research

Newspapers

• The New York Times – Pet Health & Science
• The Guardian – Animals & Veterinary Section
• The Hindu – Science & Health (Veterinary Affairs)
• The Wall Street Journal – Pet Industry and Wellness
• The Economic Times – Pet Care & Animal Health Trends
• USA Today – Pets and Health Section
• Nikkei Asia – Animal Health and Innovation Reports

Associations

• American Animal Hospital Association (AAHA)
• World Small Animal Veterinary Association (WSAVA)
• American Veterinary Medical Association (AVMA)
• International Society for Companion Animal Infectious Diseases (ISCAID)
• Pet Food Institute (PFI)
• European Pet Food Industry Federation (FEDIAF)
• National Association of Veterinary Technicians in America (NAVTA)

Public Domain Sources

• U.S. Centers for Disease Control and Prevention (CDC) – Pets & Disease Management
• European Commission – Animal Health and Welfare Portal
• Ministry of Fisheries, Animal Husbandry & Dairying (India)
• Canadian Food Inspection Agency (CFIA) – Animal Health Reports
• Animal and Plant Health Agency (UK)
• National Institutes of Health (NIH) – Comparative Medicine Section
• Department for Environment, Food & Rural Affairs (DEFRA), UK
• IndiaStat – Pet Health and Veterinary Services Statistics

Proprietary Elements:

• CMI Data Analytics Tool, and Proprietary CMI Existing Repository of information for last 8 years

*Definition: The global pet diabetes care devices market covers the sale of devices that help manage diabetes in pets such as dogs, cats, and others. This includes insulin delivery devices like insulin pens, syringes, pumps; blood/urine glucose monitoring kits containing lancets, test strips, meters; and other devices such as glucose gel or pastes for external application. The rising prevalence of diabetes in pets, growing pet ownership, increasing pet healthcare expenditure, and technological advancements in pet diabetes care devices are some of the key factors driving the growth of the global pet diabetes care devices.